WinstonWınston
AiXin Life International logo

AiXin Life International

AIXN
18
Medical - Distribution · Healthcare
Price
$0.65
+0.39 (+148.85%)
Market Cap
$16.2M
Winston Score
18
Winston is worried
Weak fundamentals across most pillars.

AiXin Life International is a small Chinese company that sells health-focused food and wellness products. Its core offerings include nutritional supplements and health foods, sold mainly to individual consumers in China. The company operates in the consumer health and food distribution space, targeting everyday buyers looking for dietary and wellness products.

AiXin generates revenue by selling its products directly to customers, likely through retail or direct-sales channels. It operates almost entirely within China and is a very small company, with a market cap that rounds to essentially zero. The operating margin of negative 169% signals the company is spending far more than it earns, which is a serious financial concern. The main risk facing AiXin is its ability to survive as a going concern — without significant improvement in profitability or access to new capital, the business faces real challenges staying operational.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-67.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+37.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

65.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$19,113 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

AiXin Life International has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 25.0M (2021) → 25.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
49.8%
Healthy — 49.8% gross margin
Operating Margin
-115.0%
Losing money on operations — -115.0%
ROCE
-36.7%
Weak — -36.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-52.3%
Shrinking sales (-52.3% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-153.6%
Burning cash (-153.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial